Safety results of ixekizumab with 1822.2 patient-years of exposure: an integrated analysis of 3 clinical trials in adult patients with psoriatic arthritis

The long-term safety was assessed in patients with psoriatic arthritis who were treated with ixekizumab in three clinical trials (SPIRIT-P1/-P2/-P3).

Source: Arthritis Research and Therapy - January 21, 2020 Category: Rheumatology Authors: Bernard Combe, Proton Rahman, Hideto Kameda, Juan D. Ca ñete, Gaia Gallo, Noah Agada, Wen Xu and Mark C. Genovese Tags: Research article Source Type: research